Replacing iron‐folic acid with multiple micronutrient supplements among pregnant women in Bangladesh and Burkina Faso: costs, impacts, and cost‐effectiveness
| العنوان: | Replacing iron‐folic acid with multiple micronutrient supplements among pregnant women in Bangladesh and Burkina Faso: costs, impacts, and cost‐effectiveness |
|---|---|
| المؤلفون: | Stephen A. Vosti, Reina Engle-Stone, Sika M Kumordzie, Laura Meinzen-Dick |
| المصدر: | Annals of the New York Academy of Sciences |
| بيانات النشر: | Wiley, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Cost effectiveness, Cost-Benefit Analysis, Iron, Iron+folic acid, iron‐folic acid, multiple micronutrient supplement, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Folic Acid, 0302 clinical medicine, History and Philosophy of Science, Pregnancy, 030225 pediatrics, Environmental health, Burkina Faso, parasitic diseases, Humans, Medicine, Micronutrients, 030212 general & internal medicine, health care economics and organizations, Bangladesh, business.industry, General Neuroscience, Pregnancy Outcome, cost‐effectiveness, Micronutrient, medicine.disease, supplementation, Female, Original Article, business |
| الوصف: | Consumption of multiple micronutrient supplements (MMS) during pregnancy offers additional benefits compared with iron‐folic acid (IFA) supplementation, but the tablets are more expensive. We estimated the effects, costs, and cost‐effectiveness of hypothetically replacing IFA supplements with MMS for 1 year in Bangladesh and Burkina Faso. Using baseline demographic characteristics from LiST and effect sizes from a meta‐analysis, we estimated the marginal effects of replacing IFA with MMS on mortality, adverse birth outcomes, and disability‐adjusted life years (DALYs) averted. We calculated the marginal tablet costs of completely replacing MMS with IFA (assuming 180 tablets per covered pregnancy). Replacing IFA with MMS could avert over 15,000 deaths and 30,000 cases of preterm birth annually in Bangladesh and over 5000 deaths and 5000 cases of preterm birth in Burkina Faso, assuming 100% coverage and adherence. We estimated the cost per death averted to be US$175–185 in Bangladesh and $112–125 in Burkina Faso. Cost per DALY averted ranged from $3 to $15, depending on the country and consideration of subgroup effects. Our estimates suggest that this policy change would cost‐effectively save lives and reduce life‐long disabilities. Improvements in program delivery and supplement adherence would be expected to improve the cost‐effectiveness of replacing IFA with MMS. |
| تدمد: | 1749-6632 0077-8923 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8257d181edf104e033e4cee47b10f6d https://doi.org/10.1111/nyas.14132 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....b8257d181edf104e033e4cee47b10f6d |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17496632 00778923 |
|---|